Accenture has invested in Iridius to accelerate the adoption of compliance-focused artificial intelligence in the life sciences sector. The partnership aims to embed regulatory compliance, traceability, and auditability directly into AI systems used by pharmaceutical and healthcare organizations.

By combining Accenture’s industry expertise with Iridius’ compliance-by-design AI platform, the collaboration seeks to streamline processes such as regulatory submissions, clinical development, and manufacturing operations. The initiative is expected to help companies speed up innovation while maintaining strict regulatory standards and data integrity.

Source: Accenture